6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh, Deok‐Kyu Cho, Jin Bae Lee, Joon‐Hyung Doh, Sang‐Hyun Kim, Jin‐Ok Jeong, Jang‐Ho Bae, Byung Ok Kim, Jang Hyun Cho, Il‐Woo Suh, Doo‐Il Kim, Hoon-Ki Park, Jong‐Seon Park, Woong Choi, Wang Soo Lee, Jihoon Kim, Ki Hong Choi, Taek Kyu Park, Joo Myung Lee, Jeong Hoon Yang, Jin-Ho Choi, Seung‐Hyuk Choi, Hyeon‐Cheol Gwon, Hyeon‐Cheol Gwon, Joo‐Yong Hahn, Young Bin Song, Taek Kyu Park, Joo Myung Lee, Jeong Hoon Yang, Jin-Ho Choi, Seung‐Hyuk Choi, Jong‐Young Lee, Woong Choi, Jang‐Ho Bae, Hun Sik Park, Jin‐Yong Hwang, Seung‐Ho Hur, Seung‐Woon Rha, Deok‐Kyu Cho, Sang Cheol Cho, Won You Kang, Seong‐Hoon Lim, Jin Bae Lee, Sang‐Hyun Kim, Kwang Soo, Rak Kyung Choi, In‐Ho Chae, Ju Hyeon Oh, Woo Jin Jang, Yong Hawn Park, Woo Jung Chun, Sang‐Hyun Kim, Jang Hyun Cho, Il‐Woo Suh, Jong‐Seon Park, Jae Woong Choi, Byung Ok Kim, Joon‐Hyung Doh, Doo-il Kim, Myung Ho Jeong, Seung Ho Kang, Wang Soo Lee, Hoon-Ki Park, Jin‐Ok Jeong, Kyung-Ju Ahn

The Lancet, 2018